|
|
|
Volumn 29, Issue 37, 2000, Pages 2023-2027
|
|
Bacterial resistance and new treatment strategies: New antistaphylococcal antibiotics;Resistance et nouvelles strategies antibiotiques: Nouveaux antibiotiques antistaphylococciques
a
a
NONE
(France)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
(3 DITHIOCARBAMOYL)CEPHALOSPORIN DERIVATIVE;
3 [5 [4 (1 AMINO 2 CARBAMOYLETHYL)PHENYL] 3 PYRROLIDINYLTHIO] 6 (1 HYDROXYETHYL) 4 METHYL 7 OXO 1 AZABICYCLO[3.2.0]HEPT 2 ENE 2 CARBOXYLIC ACID;
ANTIBIOTIC AGENT;
BMS 247243;
CEFEPIME;
CEFOTAXIME;
CEFPIROME;
CEPHALOSPORIN DERIVATIVE;
CP 5068;
DALFOPRISTIN PLUS QUINUPRISTIN;
ERTAPENEM;
ERYTHROMYCIN;
GARENOXACIN;
GATIFLOXACIN;
GEMIFLOXACIN;
GREPAFLOXACIN;
IMIPENEM;
LEVOFLOXACIN;
MEROPENEM;
METICILLIN;
MOXIFLOXACIN;
PANIPENEM;
PGE 9739390;
PGE 9882816;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
R 115685;
RWJ 333441;
TROVAFLOXACIN;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VANCOMYCIN;
ANTIINFECTIVE AGENT;
CARBAPENEM DERIVATIVE;
QUINOLONE DERIVATIVE;
QUINUPRISTIN-DALFOPRISTIN;
VIRGINIAMYCIN;
BACTERICIDAL ACTIVITY;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
DRUG EFFICACY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
META ANALYSIS;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
RABBIT;
REVIEW;
STAPHYLOCOCCUS INFECTION;
STRAIN DIFFERENCE;
TREATMENT FAILURE;
BACTERIAL ENDOCARDITIS;
DRUG COMBINATION;
MICROBIOLOGY;
PENICILLIN RESISTANCE;
ANTI-INFECTIVE AGENTS;
CARBAPENEMS;
CEPHALOSPORINS;
DRUG THERAPY, COMBINATION;
ENDOCARDITIS, BACTERIAL;
FLUOROQUINOLONES;
HUMANS;
METHICILLIN RESISTANCE;
STAPHYLOCOCCAL INFECTIONS;
VIRGINIAMYCIN;
|
|
EID: 0034598141
PISSN: 07554982
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (4)
|
|
References (9)
|
